Policy & Regulation
Kintor Pharmaceutical doses first Chinese patients in phase one GT20029 clinical trial
28 July 2021 - Kintor Pharmaceutical Limited (HKEX: 9939), a China-based clinical-stage biotechnology company, announced on Wednesday that it has dosed the first batch of subjects in its phase one cli...
NRx Pharmaceuticals' intravenous ZYESAMI (aviptadil) receives Georgian Emergency Use Authorisation
28 July 2021 - NRx Pharmaceuticals (Nasdaq: NRXP) (NRx), a clinical stage, global biopharmaceutical company, announced on Tuesday that it has received an Emergency Use Authorisation from the Nation of...
Kineta successfully completes FDA pre-IND meeting for KVA12.1
28 July 2021 - Kineta Inc, a clinical stage biotechnology company, announced on Tuesday that it has successfully completed a pre-IND (Investigational New Drug) meeting with the US Food and Drug Admini...
Oragenics Enters into Licensing Agreement with the National Research Council of Canada, to Pursue the Rapid Development of Next-Generation SARS-CoV-2 Vaccines
28 July 2021 - - US-based development-stage company Oragenics, Inc. (NYSE American: OGEN) has entered into a licensing agreement with the National Research Council of Canada that will enable Oragenics...
Arena Pharmaceuticals and Aristea Therapeutics Establish Collaboration for Development of RIST4721 for Treatment of Serious Immune-Mediated Inflammatory Diseases
28 July 2021 - - US-based biopharmaceutical company Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and US-based immunology focused drug development company Aristea Therapeutics, Inc. have forged a strateg...
Early trail of CanSinoBIO's inhaled COVID-19 vaccine candidate indicates triggering of immune response
28 July 2021 - An early stage clinical trial has indicated that an inhaled version of CanSino Biologics' (CanSinoBIO) (HKG:6185) COVID-19 vaccine, Ad5-nCoV, triggered immune responses without ser...
Related Headlines

The Marshfield Clinic Research Institute joins TriNetX network

LISCure Biosciences and Mayo Clinic sign know-how license and development collaboration agreement and stock purchase agreement

ImmunoMet Therapeutics elects Dr Revati Shreeniwas as CMO

Mirum licenses its maralixibat to GC Pharma for the treatment of rare liver diseases in South Korea

CHMP grants positive opinion in the European Union for Otsuka's child-friendly 25 mg dispersible tablet formulation of Deltyba for the paediatric population weighing at least 10 kg with pulmonary multi-drug resistant tuberculosis

Brukinsa Approved in Canada for the Treatment of Patients with Mantle Cell Lymphoma

Adagio Therapeutics Partners with Biocon Biologics to Bring COVID-19 Antibody Treatment to Patients in India and Select Emerging Markets

SpeeDx Launches Solution for SARS-CoV-2 Variant Analysis

NeoImmuneTech Receives US FDA IND Clearance for Phase 1 Study of NT-I7 for the Treatment of Kaposi Sarcoma in Patients with or Without HIV Infection

Synaffix Inks Deal with ProfoundBio Worth up to USD 246m Providing Access to Multiple Novel Linker-Payload Technologies

Slingshot Biosciences Closes USD 23m in Series A Financing

FDA Approves Keytruda Plus Lenvima Combination for Patients with Certain Types of Advanced Endometrial Carcinoma

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization for the Use of the Moderna COVID-19 Vaccine in Adolescents (12-17 Years of Age) in the European Union

Antengene and Its Partners Publish Preclinical Data Demonstrating the Encouraging Activity of Selinexor in the Prevention and Treatment of SARS-CoV-2 Infections

Anivive's GC376 Reduces COVID-19 Replication, Shows Potential as New Post-Infection Treatment